Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
Michel Cabrera Ortega, Cardiologist at Saint John of God Sanitary Park, shared a post on LinkedIn:
“LAAC vs OAC: Which risk are we trading?
Left atrial appendage closure is increasingly discussed as an alternative to long-term oral anticoagulation for stroke prevention in atrial fibrillation.
But recent randomized evidence reminds us that the comparison is more complex than ‘procedure versus medication.’
Overall stroke and major bleeding may be broadly similar, yet the type and timing of events differ: LAAC may reduce later nonprocedural bleeding, while potentially increasing ischemic stroke and introducing an upfront procedural risk.
So perhaps the most relevant question is not simply:
- Which strategy is better?
But rather:
- Which risk are we willing to accept for this particular patient?
LAAC should not be viewed as a universal substitute for anticoagulation, but as a different strategy with a different balance of risks.
Is LAAC ready to become first-line therapy in anticoagulation-eligible patients – or should patient selection remain the key?”
Jorge Enrique Aguiar Perez, Cardiologist at the Institute of Cardiology, shared this post on LinkedIn, adding:
“Excellent perspective.
LAAC should not be seen simply as a replacement for oral anticoagulation, but as a different risk–benefit strategy.
The key remains individualized patient selection and shared decision-making.
An important and timely discussion.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026